Gut microbiota signatures are associated with toxicity to combined CTLA-4 and PD-1 blockade

Journal:
Nature Medicine
Published:
DOI:
10.1038/s41591-021-01406-6
Affiliations:
28
Authors:
71
Institutions Authors Share
The University of Texas MD Anderson Cancer Center, United States of America (USA)
43.950000
43.950000
43.950000
43.950000
43.950000
0.62
Institute Gustave-Roussy (IGR), France
3.783333
0.05
Memorial Sloan Kettering Cancer Center (MSKCC), United States of America (USA)
3.500000
0.05
Tumour Immunology and Anti-Cancer Immunotherapy Unit, France
2.783333
0.04
Ligue Contre Le Cancer, France
2.783333
0.04
University of Paris-Saclay, France
2.450000
0.03
McGill University Health Centre (MUHC), Canada
2.000000
0.03
Parker Institute for Cancer Immunotherapy, United States of America (USA)
1.500000
0.02
University of Rochester Medical Center (URMC), UR, United States of America (USA)
1.000000
0.01
Sunnybrook Health Sciences Centre, U of T, Canada
1.000000
0.01
IRCCS European Institute of Oncology (IEO), Italy
1.000000
0.01
University of Texas Graduate School of Biomedical Sciences (GSBS), United States of America (USA)
1.000000
0.01
AstraZeneca Gaithersburg, MD, United States of America (USA)
1.000000
0.01
Baylor College of Medicine (BCM), United States of America (USA)
1.000000
0.01
University of South Florida (USF), United States of America (USA)
0.500000
0.01
Microbes Evolution Phylogeny and Infections (MEPHI), France
0.500000
0.01
Institut Hospitalo-Universitaire en Maladies Infectieuses de Marseille (IHU Méditerranée Infection), France
0.500000
0.01
Olivia Newton-John Cancer Research Institute (ONJCRI), Australia
0.250000
0.00
Monash University, Australia
0.250000
0.00
La Trobe University, Australia
0.250000
0.00